MapLight Therapeutics, Inc. - COMMON STOCK (MPLT)

CUSIP: 56565P103

Q2 2026 13F Holders as of 30 Jun 2026

Holder snapshot 6 signals
Share change
+1,584,421
SEC-reported price per share
$35.84
Indexed holders
105
Value change
+$72,781,489
Number of buys
56
Number of sells
39
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
55,600,941

Security key

56565P103

Report period

Q2 2026

Indexed institutions

105

Top holders

10

Ownership snapshot

Top reported holders of MPLT - MapLight Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Novo Holdings A/S
Disclosed value leader
Novo Holdings A/S
Comparable rows
0/15
Latest evidence
04 May 2026
13F 3/4/5 Highest disclosed value: $74,949,025 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Novo Holdings A/S has the largest disclosed position value at $74.95M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Novo Holdings A/S's linked filing trail.
Disclosed position value Top 5
Novo Holdings A/S $74.95M
FCPM III SERVICES B.V. $65.59M
T. Rowe Price Investment Manageme... $56.96M
GOLDMAN SACHS GROUP INC $40.56M
BlackRock, Inc. $27.24M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Novo Holdings A/S
13F 3/4/5
Company · 10%+ Owner
—
denominator unverified
$74,949,025
3,686,622 shares
— 31 Mar 2026
FCPM III SERVICES B.V.
13F
Company
13F
—
denominator unverified
$65,592,712
3,226,400 shares
— 31 Mar 2026
T. Rowe Price Investment Management, Inc.
13F
Company
13F
—
denominator unverified
$56,964,000
2,801,937 shares
— 31 Mar 2026
GOLDMAN SACHS GROUP INC
13F
Company
13F
—
denominator unverified
$40,555,768
1,994,873 shares
— 31 Mar 2026
BlackRock, Inc.
13F
Company
13F
—
denominator unverified
$27,236,732
1,339,731 shares
— 31 Mar 2026
Blue Owl Capital Holdings LP
13F
Company
13F
—
denominator unverified
$20,450,537
1,005,929 shares
— 31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
105
Shares
26,263,305
Indexed holders
105
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 indexed holders
80
Q2 2026 indexed holders
105
Indexed holder difference
25
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .